| L - Antineoplastic and Immunomodulating Agents | This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.
|
|
| L04 - Immunosuppressants | Immunosuppressants are defined as agents that completely or partly suppress one or more factors in the immunosystem.
|
|
| L04A - Immunosuppressants | This group comprises immunosuppressants excl. corticosteroids.
| The DDDs are based on prophylaxis of allograft transplant rejection if this is an approved indication.
|
|
| L04AF - Janus-Associated Kinase (Jak) Inhibitors | Tyrosine kinase 2 (TYK2) inhibitors are classified in this group.
| The DDD for tofacitinib is based on the treatment of rheumatoid arthritis.
|
|
|
